Welcome to our dedicated page for Arbe Robotics SEC filings (Ticker: ARBE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Arbe Robotics Ltd. (ARBE) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer listed on Nasdaq and the Tel Aviv Stock Exchange. Arbe files annual reports on Form 20-F and current reports on Form 6-K, which furnish press releases and other information on financial results, bond offerings, shareholder meetings, and conference calls.
Recent Form 6-K filings described in the available information include reports that furnish press releases on quarterly financial results, proposed and approved changes to the terms of Series A convertible bonds, follow-on offerings of those bonds, and announcements of conference calls to discuss earnings. Other 6-K filings relate to the company’s annual general meeting, including the election of directors and an increase in authorized share capital, as well as the furnishing of proxy materials.
For an investor analyzing Arbe, these filings are relevant for understanding the company’s financial performance, capital structure, and corporate governance. The financial statements and related disclosures in the Form 20-F and furnished press releases provide details on revenue, operating expenses, net loss, cash and deposits, convertible bonds, and shareholders’ equity, while meeting notices and proxy statements explain matters submitted to shareholders.
On Stock Titan, users can access Arbe’s SEC documents as they become available from EDGAR and review them alongside AI-generated summaries that highlight key points, such as changes in bond terms, reported financial metrics, and announced strategic developments. This structure is intended to make it easier to navigate lengthy filings and focus on information that the company has chosen to disclose about its radar-focused business and capital markets activities.
Arbe Robotics Ltd. is conducting a primary offering of 11,500,000 ordinary shares at $1.40 per share under its shelf registration. The underwriters have a 30‑day option to buy up to 1,725,000 additional shares, which would increase the deal size if fully exercised.
The company expects gross proceeds of $16.1 million and approximately $15.1 million in proceeds before expenses, or $17.4 million if the option is fully exercised. After underwriting fees and estimated expenses, net proceeds are estimated at about $14.8 million, or $17.1 million with full option exercise.
Arbe plans to use the cash for working capital and general corporate purposes108,859,502 as of September 30, 2025 and are expected to be 120,359,502 after the offering, or 122,084,502 if the option is fully exercised, meaning existing holders are diluted but the company gains additional funding to support its 4D imaging radar business.
Arbe Robotics Ltd. has filed a Form F-3 to register 6,044,071 ordinary shares issuable upon conversion of debentures with an aggregate principal amount of NIS 57,600,000 (approximately $18 million at the issuance-date exchange rate). These debentures, issued in Israel and listed on the TASE under ARBE.C1, bear interest of 6.5% until December 31, 2025 and 4.35% thereafter, mature on May 30, 2028, and are convertible at NIS 9.53 (approximately $2.95) per share. The debenture proceeds of approximately NIS 50,227,200 (approximately $15.7 million) are held in escrow and will be released to Arbe if specified conditions are met by December 31, 2026 or upon conversion, and Arbe plans to use any released funds for working capital and general corporate purposes. As of December 31, 2025, Arbe had 109,188,112 ordinary shares outstanding, and any conversion would dilute existing shareholders while giving debenture holders equity exposure at a premium to the share price noted in the document.
Arbe Robotics Ltd. has proposed amending its series A convertible bonds, including extending to December 31, 2026 the deadline for meeting conditions to release proceeds currently held by the bond trustee.
The trustee has called a bondholder vote on December 16, 2025 on the extension and updated terms, which would reduce the interest rate from 6.5% to 4.35% effective January 1, 2026, while keeping the conversion price at ILS 9.53 (about $2.95) per share. If approved, the Company is considering issuing additional bonds of this series, which could increase the principal outstanding to up to $20 million, from about $8.5 million currently. Arbe notes it does not expect to secure a potential strategic program award with a European OEM in the near future, but it continues to stand by its recently announced 2026 goals.
Arbe Robotics Ltd. furnished a Form 6-K noting that it issued a press release with financial results for the quarter ended September 30, 2025, and will discuss these third quarter results on a live conference call on November 17, 2025, at 8:30 a.m. Eastern Time. The call will feature co-founder and CEO Kobi Marenko and CFO Karine Pinto‑Flomenboim and will be accessible by telephone and via webcast through the company’s investor relations website, with an archived replay available online. The filing also highlights that the press release and the conference call include forward-looking statements subject to risks such as tariffs and trade policies, the impact of terrorism and hostilities in Israel including the continuing war with Hamas in Gaza and potential intensification with other parties, possible boycotts of Israeli products and stocks, and changes in the US dollar–Israeli shekel exchange rate, as further described in the company’s Form 20-F risk factors.
Arbe Robotics Ltd. (ARBE) announced it will hold its third quarter 2025 conference call on November 17, 2025 at 8:30 a.m. Eastern Time to discuss financial results. The call will feature Kobi Marenko, co-founder and CEO, and Karine Pinto-Flomenboim, CFO.
Participants can register in advance online; dial-in options include (844) 481-3015 (toll-free U.S.), 1-809-212373 (Israel toll-free), and +1 (412) 317-1880 (international). A live webcast and an archived replay will be available via the company’s Investor Relations website.
Arbe Robotics Ltd. (ARBEW) submitted a Form 144 disclosing a proposed sale of 162,158 ordinary shares with an aggregate market value of $315,170, scheduled approximately for 09/22/2025 on NASDAQ. The securities were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Ltd., totaling 4,261,734 shares at cash payment. The filing also reports recent sales by Canaan Partners Israel of 100,000 and 87,842 ordinary shares on 09/18/2025 and 09/19/2025 respectively, generating gross proceeds of $149,690.00 and $147,864.44. The filing includes the required representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice for ARBEW shows an intended sale of 87,842 ordinary shares on or about 09/19/2025 through Raymond James & Associates on NASDAQ, with an aggregate market value of $147,574.56. The filing reports that these shares were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Inc for cash, and that the filer previously sold 100,000 ordinary shares on 09/18/2025 (gross proceeds $147,684.05) by Canaan Partners Israel. The issuer outstanding share count is listed as 105,163,188. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
Form 144 notice: A holder intends to sell 100,000 ordinary shares of Arbe Robotics Ltd. (ticker ARBEW) through Raymond James & Associates on 09/18/2025 on the NASDAQ. The aggregate market value of the proposed sale is reported as $149,690.00 and the issuer has 105,163,188 shares outstanding. The shares were originally acquired on 03/30/2016 in a private placement from Arbe Robotics Ltd., with 4,261,734 shares listed as acquired on that date, and payment was in cash. No securities sold in the past three months are reported.
Arbe Robotics Ltd. reported the results of its 2025 annual general meeting. Shareholders elected Dr. Noam Arkind and Mr. Chris Van Dan Elzen as Class I directors, adding Van Dan Elzen to the company’s board.
Investors also approved an increase in Arbe’s registered share capital by NIS 7,560, representing 35,000,000 additional ordinary shares, bringing the total authorized ordinary shares to 200,000,000 and amending the Articles of Incorporation accordingly. All proposals described in the previously furnished proxy statement were approved by the required majorities.
The company noted that a press release announcing Van Dan Elzen’s election was issued on September 18, 2025 and furnished as an exhibit, and reiterated standard cautions about forward-looking statements, including risks related to marketing its chipset technology, global trade policies, and geopolitical and economic conditions affecting Israel.
Arbe Robotics Ltd. furnished a Form 6-K reporting that the company has posted its proxy statement and the form of proxy card for the 2025 Annual General Meeting on its website at https://arberobotics.com/. The filing identifies the exhibits as Exhibit 99.1 (Proxy Statement for the 2025 AGM) and Exhibit 99.2 (Form of Proxy Card for the 2025 AGM). The document lists Kobi Marenko as CEO.